CDB25:0003146 APP — AGER

Experimentally validated in Human; Orthology-inferred in Mouse, Rat, Frog, Zebrafish, Macaque, Pig, Dog, Cow, Chimp, Horse, Marmoset, Sheep

Title

Journal:; Year Published:

Abstract

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease.

Nature, 1996; PubMed, Homo sapiens APP — Homo sapiens AGER
ABSTRACT: Amyloid-beta peptide is central to the pathology of Alzheimer's disease, because it is neurotoxic--directly by inducing oxidant stress, and indirectly by activating microglia. A specific cell-surface acceptor site that could focus its effects on target cells has been postulated but not identified. Here we present evidence that the 'receptor for advanced glycation end products' (RAGE) is such a receptor, and that it mediates effects of the peptide on neurons and microglia. Increased expressing of RAGE in Alzheimer's disease brain indicates that it is relevant to the pathogenesis of neuronal dysfunction and death.
Basic Information on APP
Ligand Name: amyloid beta precursor protein
Other Symbols: AD1, alpha-sAPP
Ligand Location: secreted based on hpa, perplexity, uniprot, cell membrane based on perplexity, uniprot
HGNC Gene Symbol Report: APP
GeneCards: APP
HGNC Gene Group: Receptor ligands
Basic Information on AGER
Receptor Name: advanced glycosylation end-product specific receptor
Other Symbols: RAGE, SCARJ1, sRAGE
Receptor Location: cell membrane based on hpa, perplexity, uniprot
HGNC Gene Symbol Report: AGER
GeneCards: AGER